Slovakia

 

Penta buys one for the future in Poland

Czech-Slovak investment group Penta has acquired Polish hospital group Grupa Nowy Szpital (GNS). With this, Penta is making further inroads into the tricky Polish market. HBI asks, given the state of the Polish market, is now really the right time to buy?

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?

Market conditions right for Unilabs to sell

HBI hears rumour that pan-European laboratory and imaging group Unilabs could sell soon. We explore how its private equity owner Apax could make a much-anticipated exit. 

The deals you can expect to see in the next two months

M&A slowed to a trickle during COVID but the next six weeks will see a flood of deals. HBI examines the deals that are about to happen, the companies looking to IPO, and reviews a handful of deals that remain resolutely on hold for the moment.

Final week for bids on Penta Hospitals

Questions are surrounding the ongoing stake sale process for pan-CEE hospital chain Penta Hospitals International (PHI). Owner Penta Investments director Václav Jirků tells HBI that remaining bids are to be received by next week and rejects rumours it may pull the process entirely.

Penta shortlists investors for first-round bids on PHI

CEE firm Penta Investments' sale of a stake in its hospital business Penta Hospitals International (PHI) has progressed with NDAs signed by a dozen parties and indicative offers expected next month, director Václav Jirků tells HBI.

Penta to sell stake in hospital business; IMs out by March

CEE private equity firm Penta Investments is seeking a new investor for its hospital division, Penta Hospitals International (PHI), and aims to launch a process with investment memorandums (IMs) out by the end of February, investment director Václav Jirků tells HBI. He discusses the reason for the sale, including international expansion, and the current political turmoil surrounding Penta and its healthcare business.

$3bn Imaging AI sector will re-shape industry after watershed 2019/20

Imaging AI solutions which can read images just as well as radiologists are now demonstrably effective medical products that will revolutionise the medical imaging industry forever. $1.5bn in VC funding has been ploughed into companies developing solutions whose tech promises to transform diagnosis and improve operational efficiency. We talk to seven of them who've commercialised products in 2019/20, operators using them, and look at the sector in detail in this long-read feature.

Find Us